BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17549401)

  • 1. Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway.
    Gondi CS; Kandhukuri N; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):19-27. PubMed ID: 17549401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
    Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
    Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
    Gondi CS; Lakka SS; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Clin Cancer Res; 2007 Jul; 13(14):4051-60. PubMed ID: 17634529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells.
    Gondi CS; Kandhukuri N; Kondraganti S; Gujrati M; Olivero WC; Dinh DH; Rao JS
    Mol Cancer Ther; 2006 Dec; 5(12):3197-208. PubMed ID: 17172424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells.
    Gorantla B; Asuthkar S; Rao JS; Patel J; Gondi CS
    Mol Cancer Res; 2011 Apr; 9(4):377-89. PubMed ID: 21389187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of uPAR and cathepsin B retards cofilin dephosphorylation.
    Gondi CS; Kandhukuri N; Kondraganti S; Gujrati M; Olivero WC; Dinh DH; Rao JS
    Int J Oncol; 2006 Mar; 28(3):633-9. PubMed ID: 16465367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C; Yu J; Huang S
    Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
    Kargiotis O; Chetty C; Gogineni V; Gondi CS; Pulukuri SM; Kyritsis AP; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS
    Int J Oncol; 2008 Nov; 33(5):937-47. PubMed ID: 18949356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
    Whitley BR; Beaulieu LM; Carter JC; Church FC
    Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
    Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.
    Gupta R; Rao Gogineni V; Nalla AK; Chetty C; Klopfenstein JD; Tsung AJ; Mohanam S; Rao JS
    Int J Oncol; 2011 Apr; 38(4):973-83. PubMed ID: 21290090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.
    Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2008 Oct; 33(4):783-90. PubMed ID: 18813792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
    Kunigal S; Lakka SS; Gondi CS; Estes N; Rao JS
    Int J Cancer; 2007 Nov; 121(10):2307-16. PubMed ID: 17657740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.
    Chandrasekar N; Mohanam S; Gujrati M; Olivero WC; Dinh DH; Rao JS
    Oncogene; 2003 Jan; 22(3):392-400. PubMed ID: 12545160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
    Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
    Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels.
    Alfano D; Iaccarino I; Stoppelli MP
    J Biol Chem; 2006 Jun; 281(26):17758-67. PubMed ID: 16632475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.